.jpg)
Share
Robert L. Huffines
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has appointed Robert (“Robbie”) L. Huffines, former Global Chair of Investment Banking at JPMorgan Chase & Co., to its Board of Directors.
Mr. Huffines joins the board as an independent director and will also serve as a member of the Audit Committee.
With more than three decades of experience in investment banking and strategic financial leadership, Mr. Huffines brings deep expertise in global capital markets, corporate strategy, and governance.
During his distinguished career at JP Morgan Chase & Co., he advised numerous Fortune 500 companies on mergers and acquisitions, capital structure optimization, and long-term growth strategies across multiple industries, including healthcare, technology, and financial services.
Mr. Huffines’ appointment further strengthens Insulet’s governance framework as the company continues to scale its innovative Omnipod® platform and expand access to automated insulin delivery technology worldwide. His strategic insight and financial discipline will play an integral role in supporting Insulet’s long-term growth and operational excellence.
Related posts
